Update on in vitro cytotoxicity assays for drug development

By Niles Andrew L   Moravec Richard A   Riss Terry L  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 6, 2008-06 ,pp. : 655-669

Informa Healthcare

Access to resources Recommend Favorite

New in silico and conventional in vitro approaches to advance HIV drug discovery and design

By Maga Giovanni   Veljkovic Nevena   Crespan Emmanuele   Spadari Silvio   Prljic Jelena   Perovic Vladimir   Glisic Sanja   Veljkovic Veljko  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 1, 2013-01 ,pp. : 83-92

Informa Healthcare

Access to resources Recommend Favorite

In vitro three-dimensional tumor microenvironment models for anticancer drug discovery

By Smalley Keiran SM   Lioni Mercedes   Noma Kazuhiro   Haass Nikolas K   Herlyn Meenhard  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 1-10

Informa Healthcare

Access to resources Recommend Favorite

Induced pluripotent stem cells as cardiac arrhythmic in vitro models and the impact for drug discovery

By Šarić Tomo   Halbach Marcel   Khalil Markus   Er Fikret  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 1, 2014-01 ,pp. : 55-76

Informa Healthcare

Access to resources Recommend Favorite

Cell based in vitro and ex vivo models in metabolic disease drug discovery: nice to have or critical path?

By Hallén Stefan   Clapham John C  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 4, 2009-04 ,pp. : 417-428

Informa Healthcare

Access to resources Recommend Favorite